OTTAWA, ON – Innovative Medicines Canada (IMC) is deeply concerned with the U.S. Food and Drug Administration’s (FDA) decision to allow Florida to import drugs from Canada. “Canada simply can’t supply… Read More
Preliminary unaudited total net revenue for the fourth quarter and full year 2023 of approximately $45 million and $176 million Preliminary unaudited net product revenue for the fourth quarter and… Read More
Company well-positioned for further progress and broadening of R&D pipeline Cash resources of approximately $455 million as of December 31, 2023 (unaudited) Expected cash runway, including proceeds from recent private placement, into 2H 2027… Read More
Dr. Jeffrey Smith named Executive Vice President and Chief Medical Officer Dr. John Fann promoted to Senior VP, Process Sciences Seven new Vice Presidents appointed, underscoring commitment to leadership development VANCOUVER, BC – Zymeworks… Read More
Pioneering research traces the branching path of de novo metastatic prostate cancer, uncovering new management paradigms. The sudden onset and severity of de novo metastatic prostate cancer makes it one of the… Read More
